Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-dichloride.

Pandit-Taskar N, Larson SM, Carrasquillo JA.

J Nucl Med. 2014 Feb;55(2):268-74. doi: 10.2967/jnumed.112.112482. Epub 2013 Dec 16. Review.

2.

Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.

Pandit-Taskar N, Batraki M, Divgi CR.

J Nucl Med. 2004 Aug;45(8):1358-65. Review.

3.

Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases.

Lam MG, de Klerk JM, van Rijk PP, Zonnenberg BA.

Anticancer Agents Med Chem. 2007 Jul;7(4):381-97. Review.

PMID:
17630915
4.

[Bone metastases treated with radiopharmaceuticals].

Giammarile F.

Bull Cancer. 2013 Nov;100(11):1223-7. Review. French.

PMID:
24409472
5.

Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: samarium-153-EDTMP and radium-223.

Anderson PM, Subbiah V, Rohren E.

Adv Exp Med Biol. 2014;804:291-304. doi: 10.1007/978-3-319-04843-7_16. Review.

PMID:
24924181
6.

[Radionuclide therapy for the treatment of skeletal metastases of urological malignancies: a forgotten therapy?].

Badawi JK.

Dtsch Med Wochenschr. 2012 Aug;137(33):1645-9. doi: 10.1055/s-0032-1305201. Epub 2012 Aug 8. Review. German.

PMID:
22875692
7.

The use of radioisotopes for palliation of metastatic bone pain.

Gkialas I, Iordanidou L, Galanakis I, Giannopoulos S.

J BUON. 2008 Apr-Jun;13(2):177-83. Review.

PMID:
18555462
8.

Radium-223 dichloride in clinical practice: a review.

Florimonte L, Dellavedova L, Maffioli LS.

Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1896-909. doi: 10.1007/s00259-016-3386-5. Epub 2016 Apr 28. Review.

PMID:
27121689
9.

Radiometabolic treatment of bone-metastasizing cancer: from 186rhenium to 223radium.

Rubini G, Nicoletti A, Rubini D, Asabella AN.

Cancer Biother Radiopharm. 2014 Feb;29(1):1-11. doi: 10.1089/cbr.2013.1549. Epub 2013 Nov 1. Review.

PMID:
24180669
10.

Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223)Ra-dichloride.

Pacilio M, Ventroni G, De Vincentis G, Cassano B, Pellegrini R, Di Castro E, Frantellizzi V, Follacchio GA, Garkavaya T, Lorenzon L, Ialongo P, Pani R, Mango L.

Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):21-33. doi: 10.1007/s00259-015-3150-2. Epub 2015 Aug 13.

PMID:
26266887
11.

Our experience on pain palliation of bone metastasis with Sr-89 or Sm-153 in cancer patients resistant to a conventional analgesic therapy. A retrospective study.

Montesano T, Giacomobono S, Acqualagna G, Colandrea M, Di Nicola A, Travascio L, Giancamerla M, D'Apollo R, Toteda M, Ugolini F, Filesi M, Ronga G.

Clin Ter. 2009;160(3):193-9.

PMID:
19756320
12.

Bone-targeting radiopharmaceuticals including radium-223.

Brady D, Parker CC, O'Sullivan JM.

Cancer J. 2013 Jan-Feb;19(1):71-8. doi: 10.1097/PPO.0b013e318282479b. Review.

PMID:
23337760
13.

High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?

Bruland ØS, Nilsson S, Fisher DR, Larsen RH.

Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6250s-6257s. Review.

14.

Radiation-based approaches for therapy and palliation of advanced prostate cancer.

Lewis B, Sartor O.

Curr Opin Urol. 2012 May;22(3):183-9. doi: 10.1097/MOU.0b013e32835259d2.

PMID:
22453334
15.

Radium 223 dichloride: a multidisciplinary approach to metastatic castration-resistant prostate cancer.

Borsò E, Boni G, Galli L, Ricci S, Farnesi A, Mazzarri S, Cianci C, Mariani G, Falcone A.

Future Oncol. 2015;11(2):323-31. doi: 10.2217/fon.14.157. Epub 2014 Jul 30.

PMID:
25075962
16.

89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma.

Baczyk M, Czepczyński R, Milecki P, Pisarek M, Oleksa R, Sowiński J.

Nucl Med Commun. 2007 Apr;28(4):245-50.

PMID:
17325585
17.

[Targeted radionuclide therapy for castration-resistant prostate cancer].

Nakamura K, Ohga S, Sasaki T, Baba S, Honda H.

Nihon Rinsho. 2014 Dec;72(12):2181-5. Review. Japanese.

PMID:
25518355
18.

[Radionuclide therapy for painful bone metastases].

Szefer J, Zuchora Z.

Wiad Lek. 2004;57(5-6):280-3. Review. Polish.

PMID:
15518077
19.

[Alpha emitter radium-223 dichloride: new therapy in castration-resistant prostate cancer with symptomatic bone metastases].

Heinzer H, König F, Klutmann S.

Urologe A. 2014 Apr;53(4):519-23. doi: 10.1007/s00120-014-3436-1. Review. German.

PMID:
24604017
20.

Efficacy and toxicity of 153samarium-EDTMP in painful breast cancer bone metastases.

Dolezal J.

Onkologie. 2009 Feb;32(1-2):35-9. doi: 10.1159/000184746. Epub 2009 Jan 20.

PMID:
19209017

Supplemental Content

Support Center